Thrombosis occurs in more than 1 in 10 adults receiving PEGylated asparaginase (Asp)–based therapy for acute lymphoblastic leukemia (ALL), with a 4-fold ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) ...